Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) General Information
Description
Rights to the proprietary formulation of a medical product. It consists of proprietary formulation of budesonide for the treatment of various inflammatory and allergic conditions of the eye. Budesonide is provided for the treatment of asthma.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Acquirer
Primary Office
- Italy
Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Teva Pharmaceuticals Industries (Worldwide Ophthalmic Rights to Budesonide ) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|